Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teresa Graham
Pharma
Vabysmo soars as Roche grows through COVID sales declines
Vabysmo grew its market share since August despite Regeneron winning an FDA go-ahead for its high-dose Eylea, according to Swiss drugmaker Roche.
Angus Liu
Feb 1, 2024 11:36am
With Polivy beat, Roche fleshes out blood cancer ambitions
Oct 19, 2023 11:28am
Roche's star eye drug Vabysmo crosses blockbuster threshold
Jul 27, 2023 11:04am
Eye drug Vabysmo blasts off as Roche's biggest growth driver
Apr 26, 2023 11:07am
Roche's new pharma chief talks Tecentriq in early cancers
Apr 26, 2023 9:17am
